Novo Nordisk voluntarily recalled six batches of its GlucaGen HypoKit (glucagon for injection) on September 9, 2016. Two reports out of Europe detailed malfunction of needles on the syringe containing Sterile Water for Injection (SWFI) – an essential component of the kit.